Pharmaceutical Statistics

Cover image for Vol. 10 Issue 1

January/February 2011

Volume 10, Issue 1

Pages iii–iii, 1–85

  1. Editorials

    1. Top of page
    2. Editorials
    3. Viewpoints
    4. Main Papers
    5. Commentaries
    6. Book Reviews
    1. PSI's pharmaceutical statistics journal club (page iii)

      Julia Harris, Ann Cleverly and Mark Jones

      Article first published online: 28 JAN 2011 | DOI: 10.1002/pst.487

  2. Viewpoints

    1. Top of page
    2. Editorials
    3. Viewpoints
    4. Main Papers
    5. Commentaries
    6. Book Reviews
  3. Main Papers

    1. Top of page
    2. Editorials
    3. Viewpoints
    4. Main Papers
    5. Commentaries
    6. Book Reviews
    1. Making available information from studies sponsored by the pharmaceutical industry: some current practices (pages 60–69)

      Michael O'Kelly, Steven A. Julious, Stephen Pyke, Simon Day, Sue Todd, Jorgen Seldrup and James Matcham

      Article first published online: 20 APR 2010 | DOI: 10.1002/pst.430

    2. Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials (pages 70–73)

      James Matcham, Steven Julious, Stephen Pyke, Michael O'Kelly, Susan Todd, Jorgen Seldrup and Simon Day

      Article first published online: 24 FEB 2010 | DOI: 10.1002/pst.417

    3. The potential for bias in reporting of industry-sponsored clinical trials (pages 74–79)

      Stephen Pyke, Steven A. Julious, Simon Day, Michael O'Kelly, Susan Todd, James Matcham and Jorgen Seldrup

      Article first published online: 20 APR 2010 | DOI: 10.1002/pst.429

  4. Commentaries

    1. Top of page
    2. Editorials
    3. Viewpoints
    4. Main Papers
    5. Commentaries
    6. Book Reviews
  5. Book Reviews

    1. Top of page
    2. Editorials
    3. Viewpoints
    4. Main Papers
    5. Commentaries
    6. Book Reviews
    1. You have free access to this content

SEARCH

SEARCH BY CITATION